Michael Scolaro

Michael Scolaro

Nov 16, 2017

Group 6 Copy 123
0
    Please wait...

    About This Project

    We have invented a Nanocarrier that targets the Immune System to deliver Curcumin, an anti-inflammatory agent, to the brain for the treatment of neurodegenerative diseases, such as Chronic Traumatic Encephalopathy.

    Our preclinical study at Charles River Labs and the U. of Arizona, is being conducted to establish proof of effective nanocarrier delivery of Curcumin to the cells of the brain damaged by repeated traumatic athletic injuries to the head.

    Blast off!

    Browse Other Projects on Experiment

    Related Projects

    Thermal and Fluid Dynamical Effects on the Efficiency of Hyperpolarized Xenon Production

    The American Lung Association estimates that 32 million Americans are affected by lung diseases, many of...

    Can a Dietary Intervention Reduce Mercury Toxicity Among Native Communities in Peru?

    A state of emergency has been declared in Madre de Dios, Peru due to high levels of mercury (Hg) exposure...

    S-glutathionylation reactions in mitochondrial function and disease

    This project was an invited review that is currently under minor revision at Frontiers Cellular and Developmental...

    Backer Badge Funded